Citation Impact
Citing Papers
Guidelines on testing for the lupus anticoagulant. Lupus Anticoagulant Working Party on behalf of the BCSH Haemostasis and Thrombosis Task Force.
1991
The role of platelet adhesion receptor GPIbα far exceeds that of its main ligand, von Willebrand factor, in arterial thrombosis
2006
Inhibition of Platelet GPIbα and Promotion of Melanoma Metastasis
2009
Increased Thrombopoiesis and Platelet Activation in Hantavirus-Infected Patients
2015 StandoutNobel
Pharmacology and Management of the Vitamin K Antagonists
2008 Standout
Mechanisms of Thrombus Formation
2008 Standout
HLA and in vitro susceptibility to HIV infection
2002
Cell Biology of von Willebrand Factor
1990
Effects of Agents, Used to Treat Bleeding Disorders, on Bleeding Time Prolonged by a Very High Dose of a Direct Thrombin Inhibitor in Anesthesized Rats and Rabbits
2001
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)
2006 Standout
Elevated D-dimer level is an independent risk factor for cardiovascular death in out-patients with symptoms compatible with heart failure
2004 StandoutNobel
Contribution of platelets to tumour metastasis
2011 Standout
Glomerular thrombosis predicts progression of glomerulonephritis: Can we prevent progression?
1995
Dabigatran etexilate – a novel, reversible, oral direct thrombin inhibitor: Interpretation of coagulation assays and reversal of anticoagulant activity
2010 Standout
Effect of Activated Prothrombin Complex Concentrate or Recombinant Factor VIIa on the Bleeding Time and Thrombus Formation During Anticoagulation with a Direct Thrombin Inhibitor
2001
Partial expression of GP Ib measured by flow cytometry in two patients with Bernard-Soulier syndrome
1994 StandoutNobel
Hemostatic Factors and the Risk of Myocardial Infarction or Sudden Death in Patients with Angina Pectoris
1995 Standout
The Management of Thrombosis in the Antiphospholipid-Antibody Syndrome
1995 Standout
Safety of factor VIII inhibitor bypass activity (FEIBA®): 10‐year compilation of thrombotic adverse events
2002
The role of sexually transmitted diseases in HIV transmission
2004 Standout
Elevated Circulating Levels of von Willebrand Factor and D-Dimer in Patients with Heart Failure and Mechanical Prosthesis
1996
The Antiphospholipid Syndrome
2002 Standout
Diabetes and Atherosclerosis
2002 Standout
Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor
1990
Antiphospholipid Antibodies: Anticardiolipin and the Lupus Anticoagulant in Systemic Lupus Erythematosus (SLE) and in Non-SLE Disorders
1990
Adhesion receptors of the immune system
1990 StandoutNature
Reversal of rivaroxaban-induced anticoagulation with prothrombin complex concentrate, activated prothrombin complex concentrate and recombinant activated factor VII in vitro
2014
Initiation of Platelet Adhesion by Arrest onto Fibrinogen or Translocation on von Willebrand Factor
1996 Standout
Prevalence and clinical features of dementia associated with the antiphospholipid syndrome and circulating anticoagulants
2002
Fibrinogen-independent platelet adhesion and thrombus formation on subendothelium mediated by glycoprotein IIb-IIIa complex at high shear rate.
1989
The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition
2016 Standout
Hemostatic effect of activated factor VII without promotion of thrombus growth in melagatran-anticoagulated primates
2006
Stigma in the HIV/AIDS epidemic: a review of the literature and recommendations for the way forward
2008 Standout
Impaired Platelet Binding of Fibrinogen Due to a Lower Number of GPIIB/IIIA Receptors in Polycythemia Vera
1998 StandoutNobel
Prevention of post-ERCP pancreatitis: a comprehensive review
2004
Practice Guidelines in Acute Pancreatitis
2006 Standout
The Pharmacology and Management of the Vitamin K Antagonists
2004 Standout
Glycoprotein Ibα and von Willebrand factor in primary platelet adhesion and thrombus formation: Lessons from mutant mice
2008
Disorders Associated with Antibodies to Endothelial Cells
1989
Antiphospholipid antibodies and pregnancy
2003
Protein therapeutics: a summary and pharmacological classification
2007 Standout
FEIBA® safety profile in multiple modes of clinical and home‐therapy application
2004
Thrombosis as an intravascular effector of innate immunity
2012 Standout
Natural history and risk factors for thrombosis in 360 patients with antiphospholipid antibodies: A four-year prospective study from the italian registry
1996
Effects of human soluble thrombomodulin on experimental glomerulonephritis
2002 StandoutNobel
Detection of endothelial cell‐reactive immunoglobulin in patients with anti‐phospholipid antibodies
1991
Impact of the patient population on the risk for heparin-induced thrombocytopenia
2000 Standout
Development of the human coagulation system in the full-term infant
1987 Standout
BIOCHEMISTRY AND GENETICS OF VON WILLEBRAND FACTOR
1998 Standout
Maturation of the hemostatic system during childhood
1992 Standout
2011 Update to The Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists Blood Conservation Clinical Practice Guidelines
2011 Standout
HIV Population Dynamics in Vivo: Implications for Genetic Variation, Pathogenesis, and Therapy
1995 StandoutScience
Understanding and Addressing AIDS-Related Stigma: From Anthropological Theory to Clinical Practice in Haiti
2005
Thromboxane Synthesis and the Platelet Release Reaction in Bernard‐Soulier Syndrome, Thrombasthenia Glanzmann and Hermansky‐Pudlak Syndrome
1977 StandoutNobel
Platelets in the Myeloproliferative Syndrome
1975
Immunology and Clinical Importance of Antiphospholipid Antibodies
1991
Intraoperative Changes in Blood Coagulation and Thrombelastographic Monitoring in Liver Transplantation
1985 Standout
Tissue Distribution and Regulation of Murine von Willebrand Factor Gene Expression In Vivo
1998
Platelets in Myeloproliferative Disorders. III: Glycoprotein Profile in Relation to Platelet Function and Platelet Density
1981
Variable course of primary simian immunodeficiency virus infection in lymph nodes: relation to disease progression
1994 StandoutNobel
Permanent cell line expressing human factor VIII-related antigen established by hybridization.
1983 Standout
T Cell Studies in a Peptide-Induced Model of Systemic Lupus Erythematosus
2001 StandoutNobel
Decreased production of TGF-beta by lymphocytes from patients with systemic lupus erythematosus.
1998
Contemporary platelet function testing
2010
Infectious amplification of wild-type human immunodeficiency virus from patients' lymphocytes and modulation by reverse transcriptase inhibitors in vitro
1993
Antiphospholipid antibodies and venous thromboembolism
1995
Antiphospholipid syndrome: five year follow up.
1991
Decreased adhesion of giant (Bernard-Soulier) platelets to subendothelium
1974
Positive Effects of Combined Antiretroviral Therapy on CD4 + T Cell Homeostasis and Function in Advanced HIV Disease
1997 StandoutScience
Contact with Thymic Epithelial Cells as a Prerequisite for Cytokine-Enhanced Human Immunodeficiency Virus Type 1 Replication in Thymocytes
1998 StandoutNobel
Identification and characterization of a novel antigen complex on mouse mammary tumor cells using a monoclonal antibody against platelet glycoprotein Ic.
1988
Human immunodeficiency virus type 1 mRNA expression in peripheral blood cells predicts disease progression independently of the numbers of CD4+ lymphocytes.
1994 Nobel
Anaphylactic response to factor IX replacement therapy in haemophilia B patients: complete gene deletions confer the highest risk
1999
Thrombosis, Recurrent Fetal Loss, and Thrombocytopenia
1986
Unusually Large Plasma Factor VIII: von Willebrand Factor Multimers in Chronic Relapsing Thrombotic Thrombocytopenic Purpura
1982 Standout
Newborn Factor VIII Complex: Elevated Activities in Term Infants and Alterations in Electrophoretic Mobility Related to Illness and Activated Coagulatio
1981
The Hypercoagulable States
1985
Viral dynamics in human immunodeficiency virus type 1 infection
1995 StandoutNature
Somatic inactivation of the PHD2 prolyl hydroxylase causes polycythemia and congestive heart failure
2007 StandoutNobel
Type III Protein Secretion Systems in Bacterial Pathogens of Animals and Plants
1998 Standout
Human recombinant factor IX: safety and efficacy studies in hemophilia B patients previously treated with plasma-derived factor IX concentrates
2001
TRANSFORMING GROWTH FACTOR-β REGULATION OF IMMUNE RESPONSES
2005 Standout
von Willebrand factor in plasma: a novel risk factor for recurrent myocardial infarction and death.
1991
Abnormalities of factor VIII and platelet aggregation--use of ristocetin in diagnosing the von Willebrand syndrome
1975
Multimeric composition of factor VIII/von Willebrand factor following administration of DDAVP: implications for pathophysiology and therapy of von Willebrand's disease subtypes
1982
Prostaglandins and Thromboxanes
1978 StandoutNobel
PLATELET ABNORMALITIES IN VON WILLEBRAND'S DISEASE*
1972
Yersinia pestis--etiologic agent of plague
1997 Standout
Endothelial cells in physiology and in the pathophysiology of vascular disorders.
1998 Standout
The von Willebrand factor-binding domain of platelet membrane glycoprotein Ib. Characterization by monoclonal antibodies and partial amino acid sequence analysis of proteolytic fragments.
1986
Evaluation of the anti-cardiolipin antibody test: report of an international workshop held 4 April 1986.
1987
Risk for venous thrombosis related to antiphospholipid antibodies in systemic lupus erythematosus—A meta-analysis
1997
The biology of platelet-derived growth factor
1986 Standout
YopM inhibits platelet aggregation and is necessary for virulence of Yersinia pestis in mice
1990
Effects of Disturbed Flow on Vascular Endothelium: Pathophysiological Basis and Clinical Perspectives
2011 Standout
Synthesis of Factor VIII Antigen by Cultured Guinea Pig Megakaryocytes
1977
Von Willebrand protein binds to extracellular matrices independently of collagen.
1984
The yopM gene of Yersinia pestis encodes a released protein having homology with the human platelet surface protein GPIb alpha
1989
Platelet Physiology and Abnormalities of Platelet Function
1975 Standout
Bleeding and Coagulation Abnormalities in Alcoholic Cirrhotic Liver Disease
1982
Conjugates of dendritic cells and memory T lymphocytes from skin facilitate productive infection with HIV-1
1994 StandoutNobel
Works of Sultan Y being referenced
[Epidemiology of infection by LAV/HTLV-III virus in hemophiliacs multitransfused in France. Results of a survey conducted by 28 hemophilia centers].
1986
Involvement of heparin cofactor II in chymotrypsin neutralization and in the pancreatic proteinase—antiproteinase interaction during acute pancreatitis in man
1991
Fibrinolysis abnormalities in systemic lupus erythematosus and their relation to vasculitis.
1988
Predisposing factors to thrombosis in systemic lupus erythematosus: possible relation to endothelial cell damage.
1979
Report of the Working Party on Acquired Inhibitors of Coagulation: Studies of the “Lupus” Anticoagulant
1983
Modifications of factor VIII related antigen in hemophiliacs with acute hepatitis and sub‐clinical liver disease
1977
Electrophoretic heterogeneity of normal factor VIII/Von Willebrand protein, and abnormal electrophoretic mobility in patients with Von Willebrand's disease.
1976
[Acquired blood platelet disorders].
1970
Productive human immunodeficiency virus infection levels correlate with AIDS-related manifestations in the patient.
1990
Multicenter Retrospective Study on the Utilization of FEIBA in France in Patients with Factor VIII and Factor IX Inhibitors
1997
[The behavior of the blood platelets in hemorrhagic diseases].
1967
Bernard-Soulier syndrome: a new platelet glycoprotein abnormality. Its relationship with platelet adhesion to subendothelium and with the factor VIII von Willebrand protein.
1976
HLA typing in heavily transfused haemophiliacs with or without antibodies against Human Immunodeficiency Virus (HIV)
1987
Prevalence of Inhibitors in a Population of 3435 Hemophilia Patients in France
1992
[Hemorrhagic thrombocytic dystrophy (interaction of platelets and the Willebrand factor)].
1974